General form of registration statement for all companies including face-amount certificate companies

10. Share-Based Expense (Tables)

v3.19.2
10. Share-Based Expense (Tables)
3 Months Ended 12 Months Ended
Mar. 31, 2019
Dec. 31, 2018
Schedule of Share-Based Compensation Expense
    Three Months Ended March 31,  
    2019     2018  
Research and development expenses   $ 11,418     $ 60,345  
General and administrative expenses     222,522       345,849  
    $ 233,940     $ 406,194  
    Year Ended December 31,  
    2018     2017  
Research and development expenses   $ 203,030     $ 101,401  
General and administrative expenses     1,228,757       1,691,692  
    $ 1,431,787     $ 1,793,093  
Common Stock Awards [Member]    
Common stock awards  
    Number of shares  
Balance as of January 1, 2017     2,483  
Granted     3,484  
Issued     (732 )
Balance as of December 31, 2017     5,235  
Granted     2,167  
Issued      
Balance as of December 31, 2018     7.402  
Employee Stock Options [Member]    
Assumptions used  
    Year Ended December 31,  
    2018     2017  
Weighted-average expected dividend yield (%)            
Weighted-average expected volatility (%)     118.03       111.37  
Weighted-average risk-free interest rate (%)     2.90       1.79  
Weighted-average expected life of option (years)     5.90       5.36  
Weighted-average exercise price ($)     36.60       40.08  
Option activity  
    Number of
shares
    Weighted-
average
exercise
price
    Weighted-
average
remaining
life
(years)
    Aggregate
intrinsic
value
 
Outstanding as of January 1, 2017     99,476     $ 53.16       8.94     $ 526,073  
Granted     58,334       40.08                  
Expired     (9,446 )     55.32                  
Outstanding as of December 31, 2017     148,364       47.88       8.53     $ 5,273  
Granted     8,334       36.60                  
Expired     (9,245 )     68.76                  
Outstanding as of December 31, 2018     147,453     $ 45.96       8.17     $  
                                 
Vested or expected to vest as of December 31, 2018     145,370     $ 46.20       8.16     $  
                                 
Exercisable as of December 31, 2017     60,992     $ 58.08       7.44     $ 5,273  
Exercisable as of December 31, 2018     96,015     $ 49.32       7.92     $  
Non-vested option activity  
    Number of
shares
    Weighted-
average
grant date
fair value
 
Balance as of January 1, 2018     87,373     $ 34.32  
Granted     8,334     $ 31.56  
Forfeited     (556 )   $ 34.92  
Vested     (43,712 )   $ 36.60  
Balance as of December 31, 2018     51,439     $ 31.80  
Non Employee Stock Options [Member]    
Option activity  
    Number of
shares
    Weighted-
average
exercise
price
    Weighted-
average
remaining
life
(years)
    Aggregate
intrinsic
value
 
Outstanding as of January 1, 2017     4,787     $ 90.84       7.23     $  
Expired     (61 )     124.08                  
Outstanding as of December 31, 2017     4,726       90.36       6.31     $  
Granted     834       23.16                  
Expired     (263 )     219                  
Outstanding as of December 31, 2018     5,297     $ 73.44       5.40     $  
                                 
Vested or expected to vest as of December 31, 2018     5,297     $ 73.44       5.40     $  
                                 
Exercisable as of December 31, 2017     4,727     $ 90.36       6.31     $  
Exercisable as of December 31, 2018     5,297     $ 73.44       5.40     $  
Non-vested option activity  
    Number of
shares
    Weighted-
average
grant date
fair value
 
Balance as of January 1, 2018         $  
Granted     834     $ 20.76  
Vested     (834 )   $ 20.76  
Balance as of December 31, 2018         $